Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine

Bioprinting: From Tissue and Organ Development to in Vitro Models

(2020) Carlos Mota et al.   CHEMICAL REVIEWS

Establishment of a PDX tumor from Hepatitis C Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy

(2020) Mustafa Nazzal et al.   HEPATOLOGY

Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model

(2020) Yuwei Wu et al.   IMMUNOLOGY LETTERS

Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research

(2020) Lejia Sun et al.   Frontiers in Oncology

Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma

(2019) Cheng Zhou et al.   HEPATOBILIARY SURGERY AND NUTRITION

Volumetric additive manufacturing via tomographic reconstruction

(2019) Brett E. Kelly et al.   SCIENCE

A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy

(2019) Hee-Gyeong Yi et al.   Nature Biomedical Engineering

Hepatocellular Carcinoma

(2019) Augusto Villanueva   NEW ENGLAND JOURNAL OF MEDICINE

Multivascular networks and functional intravascular topologies within biocompatible hydrogels

(2019) Bagrat Grigoryan et al.   SCIENCE

Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma

(2019) Zhen-Li Li et al.   HEPATOBILIARY SURGERY AND NUTRITION

Liver organoids: from basic research to therapeutic applications

(2019) Nicole Prior et al.   GUT

3D bioprinting of collagen to rebuild components of the human heart

(2019) A. Lee et al.   SCIENCE

Cancer modeling meets human organoid technology

(2019) David Tuveson et al.   SCIENCE

Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels

(2019) Mark A. Skylar-Scott et al.   Science Advances

Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer

(2018) Eliza Li Shan Fong et al.   BIOMATERIALS

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

(2018) Masatoshi Kudo et al.   LANCET

Hepatocellular carcinoma

(2018) Alejandro Forner et al.   LANCET

3D printed tissue engineered model for bone invasion of oral cancer

(2018) Thafar Almela et al.   TISSUE & CELL

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

(2018) Hongmei Zeng et al.   Lancet Global Health

3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade

(2018) Amir R. Aref et al.   LAB ON A CHIP

Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies

(2018) Sandro Nuciforo et al.   Cell Reports

Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents

(2017) Qiang Gao et al.   GASTROENTEROLOGY

Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

(2017) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

(2017) Jordi Bruix et al.   LANCET

Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

(2017) Laura Broutier et al.   NATURE MEDICINE

Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival

(2017) Ahmedin Jemal et al.   JNCI-Journal of the National Cancer Institute

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line

(2016) Phyllis F. Y. Cheung et al.   Cancer Cell International

Heterogeneity of liver cancer and personalized therapy

(2016) Liang Li et al.   CANCER LETTERS

US cancer institute to overhaul tumour cell lines

(2016) Heidi Ledford   NATURE

Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer

(2016) Yoon Young Choi et al.   Scientific Reports

Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma

(2015) Weining Wang et al.   BMC CANCER

Liver cancer: Approaching a personalized care

(2015) Jordi Bruix et al.   JOURNAL OF HEPATOLOGY

Additive manufacturing techniques for the production of tissue engineering constructs

(2012) Carlos Mota et al.   Journal of Tissue Engineering and Regenerative Medicine

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

(2011) Shu Tian et al.   CANCER SCIENCE

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

(2010) A. McKenna et al.   GENOME RESEARCH

Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

(2010) Scott M. Wilhelm et al.   INTERNATIONAL JOURNAL OF CANCER

Fast and accurate short read alignment with Burrows-Wheeler transform

(2009) H. Li et al.   BIOINFORMATICS

Human microvasculature fabrication using thermal inkjet printing technology

(2009) Xiaofeng Cui et al.   BIOMATERIALS

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE